WHO ICTRP trial
A Phase II/III Randomized Clinical Trial to Study the Efficacy and Safety of the…
NL-OMON40914 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON40914 |
|---|---|
| Public title | A Phase II/III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects with Chronic Hepatitis C Virus Infection and Chronic Kidney Disease |
| Scientific title | A Phase II/III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects with Chronic Hepatitis C Virus Infection and Chronic Kidney Disease - MK5172-052 |
| Primary sponsor | Merck Sharp & Dohme (MSD) |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | The Netherlands |
| Conditions | Chronic Hepatitis C and Chronic Renal Insufficiency Liver inflammation and Kidney Disease;10047438;10038430;Chronic Hepatitis C and Chronic Renal Insufficiency;Liver inflammation and Kidney Disease |
| Interventions | The first dose of trial treatment will be administered at the trial site at Visit 2, or the Day 1 visit. Subsequent dosing will be performed once daily by the subject (i.e., unsupervised at his/her home) at approximately the same time each… |
| Registration date | Jun 26, 2014 |
| Target size | 6 |
| Secondary IDs | 2013-003858-25;NCT02092350;NL47686.056.14 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: